Ledger.Open graph →
SEC Form D · Amendment · filed March 9, 2015

KinDex Pharmaceuticals, Inc

Offering
$10.0M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeffrey S. Bland · Seattle, WAExec · DirectorNeile A. Grayson · Seattle, WAExecJeffrey J. Katke · Seattle, WADirectorRoger S. Colman · Seattle, WADirectorPaul J. Schimmel · Seattle, WADirectorLincoln J. Bouillon · Seattle, WAExecVerne O. Sedlacek · WILTON, CTExecJeffrey T. Long · WILTON, CTDirectorJohn W. Auchincloss · WILTON, CTExec · DirectorA. N. De Monico · WILTON, CTExecJames T. Hickey · Houston, TXDirectorJay T. Jackson · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗